tirzepatide and heart disease UC Irvine researchers project cardiac benefits from weight-loss medication Tirzepatide for Heart Failure with

Nearly 4 in 10 adults (39%) are currently using, have used or are considering using these medications

Postpartum weight retention is a common struggle, as: One year after giving birth, half of women and birthing people retain at least 10 pounds of pregnancy weight One quarter retain at least 20 additional pounds at one year postpartum

Many ethics committees require that behavioral and dietary interventions be tried first, creating a longer pre-enrollment period

Its an interesting objective to investigate

Therefore, prioritizing education and establishing a supportive network are vital for a successful transition away from GLP-1 medications

Most GLP-1 stalls last 2 to 8 weeks